articleTop 10% cited
Guidelines for the management of vitiligo: the European Dermatology Forum consensus
British Journal of Dermatology · 2012 · Vol. 168(1) · pp. 5–19
Alain Taı̈eb✉(Centre Hospitalier Universitaire de Bordeaux)Agustı́n Alomar(USP Institut Universitari Dexeus)Markus Böhm(University of Münster)Maria Lucia Dell’Anna(San Gallicano Hospital)A. De Pase(University of Bergamo)Viktoria Eleftheriadou(University of Nottingham)Khaled Ezzedine(Centre Hospitalier Universitaire de Bordeaux)Yvon Gauthier(Centre Hospitalier Universitaire de Bordeaux)David J. Gawkrodger(Royal Hallamshire Hospital)T. Jouary(Centre Hospitalier Universitaire de Bordeaux)Giovanni Leone(San Gallicano Hospital)Silvia Moretti(University of Florence)L. Nieuweboer‐Krobotová(University of Amsterdam)Mats J. Olsson(Uppsala University)Davinder ParsadThierry Passeron(Université Côte d'Azur)Adrian Tanew(Vienna General Hospital)Wietze van der Veen(University of Amsterdam)Nanja van Geel(Ghent University Hospital)Maxine E WhittonAlbert Wolkerstorfer(University of Amsterdam)Mauro Picardo(Istituti di Ricovero e Cura a Carattere Scientifico)
Abstract
The aetiopathogenic mechanisms of vitiligo are still poorly understood, and this has held back progress in diagnosis and treatment. Up until now, treatment guidelines have existed at national levels, but no common European viewpoint has emerged. This guideline for the treatment of segmental and nonsegmental vitiligo has been developed by the members of the Vitiligo European Task Force and other colleagues. It summarizes evidence-based and expert-based recommendations (S1 level).
melanin and skin pigmentationOlfactory and Sensory Function StudiesBiochemical Analysis and Sensing TechniquesVitiligoGuidelineMedicineDermatologyTask forceAlternative medicineFamily medicinePathologyPolitical science
MeSH terms
Administration, CutaneousAdministration, OralAdrenal Cortex HormonesAntioxidantsCombined Modality TherapyDermatologic AgentsHumansImmunosuppressive AgentsPhototherapySteroidsVitiligoTreatment OutcomeChecklistSkin Lightening PreparationsCalcineurin Inhibitors
Citations
436
FWCI
8.31
field-weighted impact
References
136
Percentile
99%
vs. same field & year
Citations per year
References
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Cell · 2007 · 20,020 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.